Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Having an on-site pathologist interpret tissue samples at endoscopic retrograde cholangiopancreatography (ERCP) can lead to immediate diagnosis, researchers report in the November 23rd…
NEW YORK (Reuters Health) – Menses and ovulation are more likely to resume spontaneously after chemotherapy if women also receive a gonadotropin-releasing hormone (GnRH) analog – but pregnancy…
NEW YORK (Reuters Health) – A study of Chernobyl survivors shows no difference in recurrence patterns between radiation-related and sporadic thyroid cancers. “Similar treatment approaches should be recommended…
NEW YORK (Reuters Health) – Brachytherapy is a viable option for prostate cancer patients 60 and younger, the authors of a new report in BJUI conclude. “Prostate cancer…
NEW YORK (Reuters Health) – New research does not support the routine use of hematopoietic stem cell transplantation (HSCT) in infants with acute lymphoblastic leukemia (ALL) with mixed…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today…
NEW YORK (Reuters Health) – Outcomes of cryoablation of small renal masses are similar whether the procedure is performed surgically or percutaneously, according the results of a meta-analysis…
NEW YORK (Reuters Health) – The likelihood that a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive breast cancer on final…
